Vimab Group AB (publ) (STO:VIMAB)
Sweden · Delayed Price · Currency is SEK 2.900
-0.060 (-2.03%)
At close: Aug 11, 2026
Vimab Group AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 342.28 | 328.64 | 330.25 | 347.82 | 229.25 | 209.04 | |
Revenue Growth | 7.47% | -0.49% | -5.05% | 51.72% | 9.67% | 10.27% |
Cost of Revenue | 237.84 | 248.67 | 207.2 | 233.02 | 164.35 | 158.51 |
Gross Profit | 104.44 | 79.97 | 123.05 | 114.8 | 64.9 | 50.53 |
Selling, General & Admin | 81.25 | 80 | 97.4 | 83.56 | 57.41 | 56.02 |
Depreciation & Amortization Expenses | 47.13 | 41.96 | 63.2 | 25.18 | 20.78 | 16.87 |
Other Operating Expenses | 14.45 | 14.96 | 1.3 | 0.61 | 16.16 | 0.35 |
Total Operating Expenses | 142.82 | 136.91 | 161.89 | 109.35 | 94.35 | 73.23 |
Operating Income | -70.91 | -77.72 | -76.91 | 5.45 | -29.45 | -21.23 |
Interest Income | - | 0.03 | 0.1 | -1.5 | 0.08 | 1.41 |
Interest Expense | - | -24.5 | -8.76 | -9.2 | -2.44 | -4.82 |
Other Non-Operating Income (Expense) | -15.71 | - | - | - | - | - |
Total Non-Operating Income (Expense) | -15.71 | -24.46 | -8.67 | -10.7 | -2.37 | -3.41 |
Pretax Income | -71.31 | -102.18 | -85.58 | -5.25 | -31.82 | -24.64 |
Provision for Income Taxes | 0.5 | 0.5 | 0.76 | -1.16 | -2.4 | 0.56 |
Net Income | -92.66 | -101.68 | -84.82 | -6.41 | -34.22 | -24.09 |
Minority Interest in Earnings | - | 0 | -7.88 | -2.15 | - | - |
Net Income to Common | -70.81 | -101.68 | -76.94 | -4.26 | -34.22 | -24.09 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 31 | 26 | 23 | 21 | 10 | 3 |
Shares Outstanding (Diluted) | 31 | 26 | 23 | 21 | 10 | 3 |
Shares Change | 27.65% | 12.12% | 10.99% | 110.97% | 265.91% | - |
EPS (Basic) | -3.20 | -3.90 | -3.30 | -0.30 | -1.60 | -8.90 |
EPS (Diluted) | -3.20 | -3.90 | -3.30 | -0.30 | -1.60 | -8.90 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -56.2 | -22 | -0.58 | 6.4 | 1.21 | -8.58 |
Free Cash Flow Growth | - | - | - | 428.74% | - | - |
Free Cash Flow Per Share | -1.84 | -0.84 | -0.03 | 0.31 | 0.12 | -3.16 |
Gross Margin | 30.51% | 24.33% | 37.26% | 33.01% | 28.31% | 24.17% |
Operating Margin | -20.72% | -23.65% | -23.29% | 1.57% | -12.85% | -10.16% |
Profit Margin | -27.07% | -30.94% | -25.68% | -1.84% | -14.93% | -11.52% |
FCF Margin | -16.42% | -6.69% | -0.18% | 1.84% | 0.53% | -4.10% |
EBITDA | -52.71 | -77.72 | -76.91 | 30.63 | -29.45 | -4.36 |
EBITDA Margin | -15.40% | -23.65% | -23.29% | 8.81% | -12.85% | -2.09% |
EBIT | -70.91 | -77.72 | -76.91 | 5.45 | -29.45 | -21.23 |
EBIT Margin | -20.72% | -23.65% | -23.29% | 1.57% | -12.85% | -10.16% |
Effective Tax Rate | -0.71% | -0.49% | -0.88% | 22.13% | 7.56% | -2.25% |